Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
group_3_presentation_2_-_lysergic_acid_diethylamide_lsd [2017/11/03 23:47] rajendaa |
group_3_presentation_2_-_lysergic_acid_diethylamide_lsd [2018/01/25 15:18] (current) |
||
|---|---|---|---|
| Line 219: | Line 219: | ||
| Grob C. (2002). Conversation with Albert Hofmann. In Grob C (Ed.), //Hallucinogens: A Reader// (pp. 15–22). New York, NY, USA: Tarcher/Putnam. | Grob C. (2002). Conversation with Albert Hofmann. In Grob C (Ed.), //Hallucinogens: A Reader// (pp. 15–22). New York, NY, USA: Tarcher/Putnam. | ||
| - | Hermann, E. (2016). //What You Should Know About Quitting LSD//. Retrieved from https://www.recovery.org/topics/quitting-lsd/ | + | HISTORY.com. (n.d.). History of LSD. [online] Available at: http://www.history.com/topics/history-of-lsd [Accessed 4 Nov. 2017]. |
| + | |||
| + | Hermann, E. (2016). //What You Should Know About Quitting LSD//. Retrieved from https://www.recovery.org/topics/quitting-lsd/ | ||
| + | |||
| + | Hermle, L., Simon, M., Ruchsow, M., & Geppert, M. (2012). Hallucinogen-persisting perception disorder. //Therapeutic Advances in Psychopharmacology//, 2(5), 199–205. http://doi.org/10.1177/2045125312451270 | ||
| + | |||
| + | International Narcotics Control Board (2013). Economic Consequences of Drug Abuse. International Narcotics Control Board, pp.1-4. | ||
| Kast, E. C., & Collins, V. J. (1964). Study of lysergic acid diethylamide as an alangestic agent. //Anesthesia and Analgesia, 43//, 285–291. Retrieved from https://insights.ovid.com/pubmed?pmid=14169837 | Kast, E. C., & Collins, V. J. (1964). Study of lysergic acid diethylamide as an alangestic agent. //Anesthesia and Analgesia, 43//, 285–291. Retrieved from https://insights.ovid.com/pubmed?pmid=14169837 | ||
| Line 242: | Line 248: | ||
| National Institute on Drug Abuse (NIDA). (2009). //Hallucinogens: LSD, Peyote, Psilocybin, and PCP.// Retrieved from https://www.drugabuse.gov/sites/default/files/hallucinogens09.pdf | National Institute on Drug Abuse (NIDA). (2009). //Hallucinogens: LSD, Peyote, Psilocybin, and PCP.// Retrieved from https://www.drugabuse.gov/sites/default/files/hallucinogens09.pdf | ||
| + | |||
| + | Newcomb, M. D., & Bentler, P. M. (1988). Impact of adolescent drug use and social support on problems of young adults: A longitudinal study. //Journal of abnormal psychology//, 97(1), 64. | ||
| Nichols, D.E. (2016). Psychedelics. //Pharmacological Reviews, 68(2)//, 264-355. https://doi.org/10.1124/pr.115.011478 | Nichols, D.E. (2016). Psychedelics. //Pharmacological Reviews, 68(2)//, 264-355. https://doi.org/10.1124/pr.115.011478 | ||
| + | |||
| + | Noushad, F., Al Hillawi, Q., Siram, V., & Arif, M. (2015). 25 years of Hallucinogen Persisting Perception Disorder-A diagnostic challenge. //British Journal of Medical Practitioners//, 8(1), 37-40. | ||
| Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The pharmacology of lysergic acid diethylamide: a review. //CNS Neuroscience & Therapeutics, 14(4)//, 295–314. https://doi.org/10.1111/j.1755-5949.2008.00059.x | Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The pharmacology of lysergic acid diethylamide: a review. //CNS Neuroscience & Therapeutics, 14(4)//, 295–314. https://doi.org/10.1111/j.1755-5949.2008.00059.x | ||
| Line 250: | Line 260: | ||
| PubChem. (2017). //Lysergide//. Retrieved from https://pubchem.ncbi.nlm.nih.gov/compound/5761 | PubChem. (2017). //Lysergide//. Retrieved from https://pubchem.ncbi.nlm.nih.gov/compound/5761 | ||
| + | |||
| + | Ramm, B. (2017). The LSD cult that transformed America. [online] Bbc.com. Available at: http://www.bbc.com/culture/story/20170112-the-lsd-cult-that-terrified-america [Accessed 4 Nov. 2017]. | ||
| + | |||
| + | Rothstein, E. (2008). How LSD Altered Minds and a Culture Along With It. [online] Nytimes.com. Available at: http://www.nytimes.com/2008/05/05/arts/05conn.html [Accessed 4 Nov. 2017]. | ||
| Ruck, C. A., Bigwood, J., Staples, D., Ott, J., & Wasson, R. G. (1979). Entheogens. //Journal of Psychedelic Drugs, 11(1–2)//, 145–146. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/522165 | Ruck, C. A., Bigwood, J., Staples, D., Ott, J., & Wasson, R. G. (1979). Entheogens. //Journal of Psychedelic Drugs, 11(1–2)//, 145–146. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/522165 | ||
| + | |||
| + | Samhsa.gov. (2015). Substance Use Disorders | SAMHSA - Substance Abuse and Mental Health Services Administration. [online] Available at: https://www.samhsa.gov/disorders/substance-use [Accessed 4 Nov. 2017]. | ||
| Savage, C., & McCabe, O.L. (1973). Residential psychedelic (LSD) therapy for the narcotic addict: a controlled study. //Arch Gen Psychiatry, 28//, 808-814. https://doi.org/10.1001/archpsyc.1973.01750360040005 | Savage, C., & McCabe, O.L. (1973). Residential psychedelic (LSD) therapy for the narcotic addict: a controlled study. //Arch Gen Psychiatry, 28//, 808-814. https://doi.org/10.1001/archpsyc.1973.01750360040005 | ||
| + | |||
| + | Saxe, L., Kadushin, C., Beveridge, A., Livert, D., Tighe, E., Rindskopf, D., … Brodsky, A. (2001). The Visibility of Illicit Drugs: Implications for Community-Based Drug Control Strategies. //American Journal of Public Health//, 91(12), 1987–1994. | ||
| Schiff, P. L. (2006). Ergot and its alkaloids. //American Journal of Pharmaceutical Education, 70(5)//, 98. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1637017/ | Schiff, P. L. (2006). Ergot and its alkaloids. //American Journal of Pharmaceutical Education, 70(5)//, 98. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1637017/ | ||
| + | |||
| + | Shroder, T. (2014). The Accidental, Psychedelic Discovery of LSD. [online] The Atlantic. Available at: https://www.theatlantic.com/health/archive/2014/09/the-accidental-discovery-of-lsd/379564/ [Accessed 4 Nov. 2017]. | ||
| Smith, P. (2015). //7 People Who Say They Owe Their Huge Success to Psychedelics//. Retrieved from https://www.alternet.org/drugs/seven-high-achievers-credit-psychedelics-their-success | Smith, P. (2015). //7 People Who Say They Owe Their Huge Success to Psychedelics//. Retrieved from https://www.alternet.org/drugs/seven-high-achievers-credit-psychedelics-their-success | ||
| + | |||
| + | Wu, L.-T., Ringwalt, C. L., Mannelli, P., & Patkar, A. A. (2008). Hallucinogen Use Disorders Among Adult Users of MDMA and Other Hallucinogens. //The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions//, 17(5), 354–363. http://doi.org/10.1080/10550490802269064 | ||
